Skip to main content

3 Result(s)

within Ana Mariño Remove this filter

and

  1. No Access

    Article

    Deprescribing of non-antiretroviral therapy in HIV-infected patients

    In recent decades, the life expectancy of HIV-infected patients has increased considerably, to the extent that the disease can now be considered chronic. In this context of progressive aging, HIV-infected pers...

    José-Ramón Blanco, Ramón Morillo… in European Journal of Clinical Pharmacology (2020)

  2. No Access

    Article

    Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide

    Data are lacking regarding overdose of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF).

    Hortensia Álvarez, Ana Mariño, Nieves Valcarce, Jesús García-González… in Infection (2019)

  3. No Access

    Article

    Clinical Utility of Maraviroc

    Maraviroc belongs to the family of chemokine (C-C motif) receptor 5 (CCR5) antagonists that prevent the entry of human immunodeficiency virus (HIV) into host CD4+ T cells by blocking the CCR5 co-receptor R5. M...

    Jorge Parra, Joaquín Portilla, Dr Federico Pulido… in Clinical Drug Investigation (2011)